Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Molbio Diagnostics Ltd

NSE: MOLBIO · BSE: 544866 · Healthcare · 10 announcements

Share price
₹1,554.00
Market cap
₹17,908 Cr
Revenue (annual)
₹1,446 Cr
Net profit (annual)
₹166.6 Cr
Promoter holding
41.29%
FII holding
1.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

13:34 IST BSE
Other Announcement

Molbio Diagnostics Other Announcement

Molbio Diagnostics Limited re-appointed M/s. K.S. Kamalakara & Co as Cost Auditors for a 12-month term. The decision was finalized during a board meeting on September 25, 2026.

Execution
12 months
12:12 IST NSE
Other Announcement

Molbio Diagnostics Other Announcement

Molbio Diagnostics informed exchanges that its CIN changed from U33125GA2000PLC002909 to L33125GA2000PLC002909 post-listing. The MCA status was updated from Unlisted to Listed.

18:23 IST BSE
Other Announcement

Molbio Diagnostics Other Announcement

Molbio Diagnostics Limited has designated Mr. Darshan Raghunath Karekar as the company's Compliance Officer under the SEBI (Prohibition of Insider Trading) Regulations, 2015.